annual CAPEX:
$929.00K+$486.00K(+109.71%)Summary
- As of today (September 13, 2025), KALV annual capital expenditures is $929.00 thousand, with the most recent change of +$486.00 thousand (+109.71%) on April 30, 2025.
- During the last 3 years, KALV annual CAPEX has fallen by -$2000.00 (-0.21%).
- KALV annual CAPEX is now -34.90% below its all-time high of $1.43 million, reached on April 30, 2018.
Performance
KALV CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CAPEX:
N/ASummary
- KALV quarterly capital expenditures is not available.
Performance
KALV quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Range
Earnings dates
TTM CAPEX:
N/ASummary
- KALV TTM capital expenditures is not available.
Performance
KALV TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Range
Earnings dates
KALV CAPEX Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +109.7% | - | - |
3 y3 years | -0.2% | - | - |
5 y5 years | +322.3% | - | - |
KALV CAPEX Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -22.3% | +109.7% | ||||
5 y | 5-year | -22.3% | +1032.9% | ||||
alltime | all time | -34.9% | +5061.1% |
KALV CAPEX History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Apr 2025 | $929.00K(+109.7%) | $776.00K(+3133.3%) | $929.00K(+63.3%) |
Jan 2025 | - | $24.00K(-77.8%) | $569.00K(+0.9%) |
Oct 2024 | - | $108.00K(+414.3%) | $564.00K(+23.1%) |
Jul 2024 | - | $21.00K(-95.0%) | $458.00K(+3.4%) |
Apr 2024 | $443.00K(-63.0%) | $416.00K(+2089.5%) | $443.00K(+361.5%) |
Jan 2024 | - | $19.00K(+850.0%) | $96.00K(+4.3%) |
Oct 2023 | - | $2000.00(-66.7%) | $92.00K(-67.4%) |
Jul 2023 | - | $6000.00(-91.3%) | $282.00K(-76.4%) |
Apr 2023 | $1.20M(+28.5%) | $69.00K(+360.0%) | $1.20M(-1.4%) |
Jan 2023 | - | $15.00K(-92.2%) | $1.21M(-13.4%) |
Oct 2022 | - | $192.00K(-79.1%) | $1.40M(-10.5%) |
Jul 2022 | - | $920.00K(+969.8%) | $1.56M(+68.0%) |
Apr 2022 | - | $86.00K(-57.4%) | $931.00K(+6.0%) |
Apr 2022 | $931.00K(+1035.4%) | - | - |
Jan 2022 | - | $202.00K(-43.3%) | $878.00K(+27.2%) |
Oct 2021 | - | $356.00K(+24.0%) | $690.00K(+98.8%) |
Jul 2021 | - | $287.00K(+769.7%) | $347.00K(+323.2%) |
Apr 2021 | $82.00K(-62.7%) | $33.00K(+135.7%) | $82.00K(+43.9%) |
Jan 2021 | - | $14.00K(+7.7%) | $57.00K(+32.6%) |
Oct 2020 | - | $13.00K(-40.9%) | $43.00K(-70.1%) |
Jul 2020 | - | $22.00K(+175.0%) | $144.00K(-34.5%) |
Apr 2020 | $220.00K | $8000.00(>+9900.0%) | $220.00K(-54.8%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jan 2020 | - | $0.00(-100.0%) | $487.00K(-3.9%) |
Oct 2019 | - | $114.00K(+16.3%) | $507.00K(-17.4%) |
Jul 2019 | - | $98.00K(-64.4%) | $614.00K(-43.2%) |
Apr 2019 | $1.08M(-24.2%) | $275.00K(+1275.0%) | $1.08M(-42.8%) |
Jan 2019 | - | $20.00K(-91.0%) | $1.89M(-7.9%) |
Oct 2018 | - | $221.00K(-60.9%) | $2.05M(+9.0%) |
Jul 2018 | - | $565.00K(-47.9%) | $1.88M(+31.9%) |
Apr 2018 | $1.43M(+1828.4%) | $1.08M(+495.6%) | $1.43M(+307.7%) |
Jan 2018 | - | $182.00K(+256.9%) | $350.00K(+108.3%) |
Oct 2017 | - | $51.00K(-53.6%) | $168.00K(+43.6%) |
Jul 2017 | - | $110.00K(+1471.4%) | $117.00K(+1571.4%) |
Apr 2017 | $74.00K(-94.6%) | $7000.00(-99.4%) | $7000.00(-99.5%) |
Dec 2015 | $1.37M(+764.2%) | $1.09M(+5109.5%) | $1.37M(+286.0%) |
Sep 2015 | - | $21.00K(-73.4%) | $356.00K(+4.1%) |
Jun 2015 | - | $79.00K(-56.1%) | $342.00K(+1.2%) |
Mar 2015 | - | $180.00K(+136.8%) | $338.00K(+112.6%) |
Dec 2014 | $159.00K(+783.3%) | $76.00K(+985.7%) | $159.00K(+93.9%) |
Sep 2014 | - | $7000.00(-90.7%) | $82.00K(+9.3%) |
Jun 2014 | - | $75.00K(+7400.0%) | $75.00K(>+9900.0%) |
Mar 2014 | - | $1000.00(-200.0%) | $0.00(-100.0%) |
Dec 2013 | $18.00K(-80.2%) | -$1000.00 | -$1000.00 |
Dec 2012 | $91.00K | - | - |
FAQ
- What is KalVista Pharmaceuticals, Inc. annual capital expenditures?
- What is the all time high annual CAPEX for KalVista Pharmaceuticals, Inc.?
- What is KalVista Pharmaceuticals, Inc. annual CAPEX year-on-year change?
- What is the all time high quarterly CAPEX for KalVista Pharmaceuticals, Inc.?
- What is the all time high TTM CAPEX for KalVista Pharmaceuticals, Inc.?
What is KalVista Pharmaceuticals, Inc. annual capital expenditures?
The current annual CAPEX of KALV is $929.00K
What is the all time high annual CAPEX for KalVista Pharmaceuticals, Inc.?
KalVista Pharmaceuticals, Inc. all-time high annual capital expenditures is $1.43M
What is KalVista Pharmaceuticals, Inc. annual CAPEX year-on-year change?
Over the past year, KALV annual capital expenditures has changed by +$486.00K (+109.71%)
What is the all time high quarterly CAPEX for KalVista Pharmaceuticals, Inc.?
KalVista Pharmaceuticals, Inc. all-time high quarterly capital expenditures is $1.09M
What is the all time high TTM CAPEX for KalVista Pharmaceuticals, Inc.?
KalVista Pharmaceuticals, Inc. all-time high TTM capital expenditures is $2.05M